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In vitro infection of PHA-stimulated, normal CD41 human peripheral blood T lymphocytes (PBLs) with several HIV-1 isolates
did not result in cytopathology, despite high levels of virus replication and the fact that some of these isolates were cytopathic
in certain cell lines. In contrast, infection of unfractionated PBLs (containing CD81 as well as CD41 lymphocytes) with these
isolates always resulted in death of the infected CD41 T lymphocytes. It has been well documented that PHA stimulation and
culture of PBLs in medium containing IL-2 generates lymphokine-activated killer (LAK) cell activity which can destroy many
transformed cells and virus-infected normal cells. When CD81 T lymphocytes from PHA-stimulated PBLs were added to
HIV-1-infected purified CD41 T lymphocytes, significant lysis occurred. This cytotoxicity was not MHC class I-restricted, and
depletion of CD81 T lymphocytes from unfractionated PBL cultures shortly after HIV infection largely abolished the killing of
the infected CD41 T lymphocytes. These results demonstrated that CD81 LAK cells were killing the CD41 T lymphocytes in
unfractionated PBL cultures infected with these noncytopathic HIV-1 strains. Care is thus warranted when studying HIV
cytopathology in unfractionated PBL cultures. Morphological and DNA gel electrophoretic analyses of HIV-infected CD41 T
lymphocytes being killed by CD81 LAK cells demonstrated that apoptosis was the predominant mechanism of LAK
cell-mediated killing. In contrast, necrosis was the major mechanism involved in killing of purified CD41 T lymphocytes by
HIV-1 strains which were directly cytopathic. These findings may explain some of the discrepancies in the literature
concerning reports of either apoptotic or necrotic killing of cells by HIV in vitro. Moreover, these data strongly suggest that
direct killing by replicating HIV-1 in vivo should reveal necrotic cells and immune effector cell killing should reveal apoptotic
cells. Since the latter are much more frequently observed in vivo, perhaps immune effector-mediated depletion of CD41 T
lymphocytes is more important as a pathogenic mechanism. © 1998 Academic Press
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INTRODUCTION
Infection with HIV-1 leads to gradual depletion of
CD41 T lymphocytes and ultimately fatal immunosup-
pression (Pantaleo and Fauci, 1993). The mechanism(s)
underlying depletion of these cells in vivo is not yet
understood. HIV-1 can only productively infect CD41 T
lymphocytes which are dividing (Gowda et al., 1989;
Schnittman et al., 1990; Stevenson et al., 1990). Conse-
quently, to infect normal peripheral blood T lymphocytes
(PBLs) in vitro or to expand and isolate HIV from PBLs
from HIV-infected patients, cultures of dividing PBLs are
established using mitogen activation. It has been noted
previously, however, that the presence of CD81 T lym-
phocytes in cultured PBLs from HIV-infected subjects
could suppress HIV-1 replication and virus production
(Walker and Levy, 1989). Removal of CD81 T lymphocytes
from these cultures resulted in improved virus recovery
and greater virus production (Brinchmann et al., 1990;
Kannagi et al., 1990; Walker et al., 1991b). This antiviral
effect of CD81 T lymphocytes was not MHC class I-
restricted, which distinguished it from classical MHC
class I-restricted CD81 cytotoxic T lymphocytes (CTL-
)(Mackewicz and Levy, 1992). Similar studies using stim-
ulated PBLs from healthy HIV-negative donors did not
find reduced virus replication in unfractionated PBLs in
comparison to CD8-depleted PBLs (Kannagi et al., 1990;
Walker et al., 1991a), suggesting that some inhibitory
element was present only in PBLs from HIV-infected
subjects. However, two recent reports demonstrated that
CD81 T lymphocytes from HIV-1-seronegative individuals also
suppress virus replication in acutely infected PBL cultures
(Barker et al., 1996; Rosok et al., 1997). Since no apparent lysis
of infected CD41 T lymphocytes by CD81 T lymphocytes from
HIV1 donors could be detected in a standard 4-h 51chromium-
release assay, Walker and co-workers proposed that a se-
creted CD8-cell antiviral factor (CAF) from infected individuals
may be involved in the suppression of HIV-1 replication (Walk-
er et al., 1991a).
It is known, however, that mitogen stimulation and
culture of PBLs in medium containing IL-2 generate lym-
phokine-activated killer (LAK) cells (Ochoa et al., 1989;
Roussel et al., 1990). LAK cells have the ability to lyse
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many transformed cell lines (Roussel et al., 1990) as well
as virus-infected normal cells (Klimpel et al., 1989). Their
cytolytic activity is not MHC-restricted, and both CD81
and CD82 lymphocytes can display this activity (Brenner
et al., 1993; Mansour et al., 1990). Thus, it seems logical
that LAK cells known to be present in PHA-stimulated
PBL cultures would kill some of the infected CD41 T
lymphocytes following HIV infection. Herein, we report
that several HIV-1 isolates, which were not directly cyto-
pathic in purified PHA-stimulated CD41 T lymphocytes,
appeared cytopathic in stimulated unfractionated PBLs.
CD81 T lymphocytes present in the PBL cultures were
found to be responsible for the killing of the infected
CD41 T lymphocytes. The cytolytic effect of the CD81 T
lymphocytes was confirmed using a 51Cr-release assay
and this killing was not MHC class I-restricted. Thus,
studies examining what HIV does to lymphocytes in
mitogen-stimulated unfractionated PBL cultures need to
consider LAK-mediated killing of infected cells. The
mechanism of killing of HIV-infected CD41 T lympho-
cytes by CD81 LAK cells was found to be predominantly
via induction of apoptosis, whereas HIV-1 isolates di-
rectly cytopathic in purified CD41 T lymphocytes killed
predominantly via necrosis. These findings may help
explain discrepancies in the literature concerning how
HIV kills CD41 T lymphocytes (Bergeron and Sodroski,
1992; Chernomordik et al., 1994; Cloyd and Lynn, 1991;
Martin et al., 1994; Miller et al., 1993a; Terai et al., 1991),
i.e., induction of apoptosis by replicating HIV may actu-
ally be mediated, at least in part, by immune effector
cells, rather than virus replication.
RESULTS
Productive infection of PHA-stimulated purified CD41 T
lymphocytes with certain HIV-1 isolates (HIV-1 MCK,
AC-1, or MN) did not result in cell death, but cell death
occurred when unfractionated PBLs were used
PBLs from healthy HIV-1-negative donors were de-
pleted of CD81 T lymphocytes by cell panning. The
purified CD41 T lymphocytes consisted of greater than
95% CD4 cells and less than 1% CD81 T lymphocytes, as
determined by staining with FITC- or PE-conjugated anti-
CD4 or CD8 mAbs and flow cytometry. These CD41 T
lymphocytes were then stimulated with PHA and cul-
tured in IL-2 medium for a total of 3–5 days before
inoculation with various HIV-1 isolates. Some HIV-1 iso-
lates (HIV-1213, IIIB, RF, and TP-1) were very cytopathic in
purified CD41 T lymphocytes, as expected. The infected
cells began to die at 2 days postinfection, and by 4 days
postinfection, the majority of the cells were producing
virus and were dying, as determined by trypan blue
exclusion (data not shown). Several other HIV-1 isolates
(HIVMCK, AC-1, and MN), however, were not cytopathic
in purified CD41 T lymphocytes (Fig. 1)(data with HIVMN
are similar but are not shown). Two of these (HIVAC-1
and MN) had been shown to be cytopathic in certain cell
lines (Cloyd and Moore, 1990). In contrast, infection of
unfractionated PBLs (m.o.i ' 1) with these HIV strains
resulted in the death of approximately 40–50% of the
cells (Fig. 1). These HIV strains replicated in the CD41 T
lymphocytes as well as the strains that were cytopathic
(Fig. 2), showing that the viral stocks used were good.
Thus, cells were dying in the infected unfractionated
PBLs but not in purified CD41 T lymphocytes. The extent
of HIV infection of the purified CD41 T lymphocyte cul-
tures was further monitored by immunostaining of the
cells with diluted pooled sera from HIV1 patients and
flow cytometry. This showed that nearly all of the CD41
T lymphocytes infected with HIVAC-1 and HIVMCK were
producing viral antigens by 4–6 days postinfection (Figs.
3B and 3D). The CD4 cells remained viable and retained
expression of CD4, while HIV expression gradually de-
clined following a peak. This decline always occurs dur-
ing the chronic phase of HIV replication and results in
latent infection (Li et al., 1996). Quantitation of virus
released into the culture supernatants by p24 antigen-
capture EIA further demonstrated that active virus repli-
cation was taking place in both the purified CD41 T
lymphocytes and unfractionated PBL cultures (Figs. 4A
and 4B), but the amounts of virus released by unfraction-
ated PBLs were four- to fivefold less at the peak of
production than the same number of purified CD41 T
lymphocytes (Figs. 4A and 4B). These data demonstrated
that low titered virus stocks or poor infections were not
the explanation for noncytopathicity of HIVs MCK and
AC-1 in purified CD4 T cells. It was of interest, therefore,
to determine what cells in the unfractionated PBL cul-
tures were dying after infection with these viruses.
CD41 T lymphocytes were killed in unfractionated
PBLs infected in vitro with noncytopathic
HIV-1 isolates
To determine what cells died in infected unfraction-
ated PBLs, the numbers of CD41 and CD81 cells were
monitored by immunostaining and flow cytometry. In the
unfractionated PBL cultures, all the CD41 T lymphocytes
became infected by the HIV-1 isolates studied and were
gradually depleted from the cultures (Fig. 5). The disap-
pearance of CD4 cells was not due to significant down-
regulation of cell surface CD4 molecules since the per-
centages of CD4 plus CD8 cells approximates the per-
centage of CD3 cells at each time point postinfection
(Fig. 5).
LAK cell activity was present in the PHA-stimulated
unfractionated PBL cultures
It has been shown that in vitro culture of PBLs in medium
containing IL-2 generates LAK cell activity (Roussel et al.,
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1990). LAK cells can kill many transformed cell lines and
virus-infected normal cells, but not uninfected normal PBLs
(Klimpel et al., 1989). Most in vitro studies of HIV-1 infections
of PBLs have used cells stimulated with mitogens (PHA or
ConA) or anti-CD3 mAbs and IL-2. In our cultures, we used
PHA (4 mg/ml) and IL-2 (20 units/ml). To determine if LAK
cell activity was generated in our cultures, we performed
51chromium-release assays using several established cell
lines (K562, VB, CEM, CEM.NKr) and HIV-infected cell lines
either latently infected (ACH.2) or actively producing virus
(35.8) as target cells. All of these cell lines, but not normal
PBLs, could be lysed efficiently by the PHA-stimulated (un-
infected) PBLs (Fig. 6). Thus, our unfractionated PBL cul-
tures used for HIV-1 infection possessed LAK activity.
HIV-infected CD41 T lymphocytes were killed
by CD81 LAK cells
We then investigated whether the LAK cells present in
the unfractionated PBL cultures could kill HIV-infected nor-
mal CD41 T lymphocytes. Purified CD41 T lymphocytes
were prepared and infected with HIV-1MCK as described
above. At 4 days postinoculation, when almost all the cells
FIG. 1. Cell viability after infection of unfractionated PBLs and purified CD41 T lymphocytes with HIVMCK (A) or HIVAC-1 (B) at m.o.i ' 1.
PHA-stimulated unfractionated PBLs (4 3 106)(PBLs) and purified CD41 PBLs (2 3 106)(CD4) from HIV-seronegative donors were infected in vitro and
cultured in medium containing IL-2 (20 units/ml). Cell viability was monitored by trypan blue exclusion. Data are expressed as means 6 SD from three
experiments; uninf., uninfected.
FIG. 2. Antigen capture EIA quantitation of HIV-1 capsid protein
p24 released into the supernatants from purified CD4 T lymphocyte
blasts infected with cytopathic HIV isolates 213 and RF and noncy-
topathic isolates MCK and AC-1. The culture medium was changed
every other day.
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were HIV antigen-positive as determined by flow cytometry,
they and uninfected control CD41 T lymphocytes were
labeled with 51chromium and used as target cells for LAK
cytotoxicity assays as described under Materials and Meth-
ods. The effector cells were from PHA-stimulated unin-
fected or HIV-infected PBLs. There was no cytolysis of
uninfected CD4 T cells with either effector (Fig. 7A), but the
infected CD41 T lymphocytes were significantly lysed by
both effector cells at various effector:target (E:T) ratios.
Thus, LAK cells in PBL cultures could kill HIV-infected
normal CD41 T lymphocytes. Depletion of CD81, but not
CD41, T cells from the PBL effectors largely abolished this
lysis (Fig. 7B), showing that the LAK cells were mostly
CD81 T cells. Further experiments showed that the lysis of
HIVMCK-infected CD4
1 T lymphocytes was not MHC class
I-restricted using effectors and targets from different donors
(Fig. 7C). Immunostaining with anti-CD16 mAb and flow
cytometry showed that the percentage of CD16 cells (NK
cells) in PHA-stimulated PBLs was less than 0.2% by 8 to 10
days of in vitro culture (data not shown). These data, plus
the results from the previous experiments, demonstrated
that the killing of CD41 T lymphocytes in HIVMCK-infected
unfractionated PBLs was predominantly due to CD81 LAK
cell activity.
LAK-mediated killing of HIV-1-infected CD41 T
lymphocytes in unfractionated PBLs was via
induction of apoptosis
A number of studies have presented evidence that HIV
replication in T cells or PBLs results in induction of apopto-
sis (Terai et al., 1991; Oyaizu et al., 1993), while other studies
FIG. 3. Infection of purified CD41 PBL PHA blasts with HIVAC-1 (B) or HIVMCK (D) (m.o.i ' 1) and analysis of lymphocyte subpopulations by flow
cytometry. For each experiment, 10 3 106 CD41 T lymphocytes (. 98% pure) were used for infection. Monoclonal antibodies OKT4, OKT8, and OKT3
were used to stain CD4, CD8, and CD3 cells, respectively. Goat anti-mouse IgG (GAM)-FITC was used as secondary antibody and a control for
nonspecific staining (without primary antibody). For staining HIV-infected cells, diluted pooled sera from HIV1 patients were used, followed by staining
with goat anti-human IgG (GAH)-PE or -FITC. Pooled normal human serum (NHS) was used as a control. Uninfected cells (control, A and C) gave less
than 8% nonspecific staining with patient sera at days 6, 13, and 16 of culture. The nonspecific staining (background staining) of infected cells with
NHS was also very low, similar to that of uninfected control cells. Data shown are representative of five HIVMCK and two HIVAC-1 experiments.
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of the mechanism of HIV cytopathology have shown cell
membrane perturbations and DNA smearing which are
characteristics of necrotic death (Cloyd and Lynn, 1991;
Bergeron and Sodroski, 1992; Fermin and Garry, 1992;
Miller et al., 1993a). It is known that NK and LAK cells kill
target cells via induction of apoptosis (Knight et al., 1993).
We next examined how HIV-infected CD41 T lymphocytes
died in cultures of PBLs. Agarose gel electrophoresis of
DNA extracted from a coculture of CD81 PBLs with purified
CD41 PBLs after infection with noncytopathic HIVMCK
showed evidence of a DNA ladder, characteristic of apop-
tosis (Fig. 8A, lanes 5 and 6). EM examination of these PBLs
at 2 and 4 h post-coculture showed cell shrinkage, chro-
matin condensation, and breakdown of condensed chro-
matin material (apoptotic bodies), which are also charac-
teristic of apoptosis (Fig. 8C).
Killing of HIV-1-infected CD41 T lymphocytes
by directly cytopathic HIV-1 isolates was
a necrotic process
As mentioned earlier, some HIV-1 isolates (HIV213,
IIIB, RF, and TP-1) were very cytopathic for purified
CD41 T lymphocytes. Cells began to die at 2 days
postinfection, and by 4 to 5 days postinfection, the
majority of the cells were dead, as determined by
trypan blue exclusion. Agarose gel electrophoresis of
the DNA extracted from HIV213-infected purified CD4
1
T lymphocytes showed a smear pattern at 4 days
postinfection (Fig. 9A, lane 4). Consistent with this
result, ultrastructural studies of HIV213-infected cells
exhibited cell membrane damage, cell swelling, and
decreased chromatin material which are observations
characteristic of necrosis (Fig. 9C). Agarose gel elec-
trophoresis of DNA extracted from HIVIIIB or TP-1-in-
fected CD41 T lymphocytes also showed a smear,
consistent with necrosis (Fig. 9A, lanes 5 and 6).
FIG. 5. Disappeance of CD41 T lymphocytes from unfractionated
PBL PHA blasts after HIVMCK or AC-1 infection. After stimulation with PHA
(4 mg/ml) and culturing in medium containing IL-2 (20 units/ml) for 3 to
4 days, unfractionated PBLs were infected with HIV. The percentage of
CD3-positive cells was greater than 96%, as determined by flow cy-
tometry. Following infection, the percentages of CD3, CD4, CD8, and
HIV-positive cells were determined as described previously (see Fig. 3).
Mock-infected PBLs were used as controls. Data shown are represen-
tative of six independent experiments. Nonspecific binding due to dying
or dead cells in HIVMCK- and HIVAC-1-infected PBLs was about 5–10%,
although gating by forward and side scatter was only on live cells.
FIG. 4. Antigen-capture EIA quantitation of HIV p24 levels in super-
natants of cultures of unfractionated PBLs and purified CD41 PBL
blasts (CD4) infected with HIVMCK (A) or HIVAC-1 (B).
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DISCUSSION
It has been known for quite some time that the pres-
ence of CD81 T lymphocytes in PBL cultures could
suppress HIV-1 replication and virus production (Walker
et al., 1986; Brinchmann et al., 1990). Removal of CD81 T
lymphocytes greatly improved virus recovery from PHA-
stimulated and IL-2-grown PBLs from HIV-infected indi-
viduals (Walker and Levy, 1989; Walker et al., 1986, 1991b;
Mackewicz and Levy, 1992). The antiviral activity exerted
by activated CD81 T lymphocytes was non-MHC class
I-restricted and, thus, was different from that of classical
CD81 CTL activity. Early studies failed to detect signifi-
cant cytolysis of infected CD41 T lymphocytes by acti-
vated CD81 T lymphocytes in a 4-h 51chromium-release
assay, which suggested the involvement of a secreted
CD8 CAF (Walker et al., 1991a). This was strengthened by
studies showing that HIV production was sometimes
reduced in CD41 T lymphocytes separated from the
CD81 T lymphocytes in two-chamber wells (Mackewicz
and Levy, 1992). However, the CD81 T lymphocytes had
to be from HIV-infected subjects to show inhibition of HIV
production. Why LAK cell activity was not observed in
these studies is puzzling, for it should have been
present. It has been thoroughly documented that mito-
gen-stimulated unfractionated PBLs grown in IL-2 contain con-
siderable LAK cell activity (Roussel et al., 1990). Indeed, other
studies have shown that CD81 T lymphocytes from HIV-1-
seronegative individuals can suppress HIV replication in vitro
(Rosok et al., 1997; Barker et al., 1996).
The discrepancy between our findings and the above
studies, which could not detect any cytolysis of HIV-1-
infected CD41 T lymphocytes by mitogen-activated
CD81 T lymphocytes, may be due to differences in the
assay procedures used (Walker et al., 1991a). In the
Walker et al. report, the labeling of CD41 T lymphocytes
with 51chromium was performed for 1 h and cytolysis
was determined after 4 h of incubation with effector cells
(CD81 T lymphocytes). In our experiments, we labeled
the CD41 T lymphocytes for 12 h, and the incubation time
with the effector cells was extended to 8 h. This proce-
dure has been shown to more readily elucidate LAK
activity (Klimpel et al., 1989). We did perform experiments
following Walker and co-worker’s (1991a) protocol and
also could not detect significant cytolysis (data not
shown).
In vitro studies have shown that many HIV-1 isolates
are cytopathic for CD4 T cell lines and activated PBLs
(Lifson et al., 1986; Popovic et al., 1984), but many non-
cytopathic strains have been isolated (Cheng-Mayer et
al., 1989; Cloyd and Moore, 1990; Evans et al., 1988; Kong
et al., 1988). Our finding that some HIV-1 isolates derived
from AIDS patients (HIVMCK, AC-1, MN) were not cytopathic
in purified normal CD41 T lymphocyte blasts, but were in
T cell lines (Cloyd and Moore, 1990) suggests that a
reevaluation of HIV cytopathicity in purified CD4 blasts
may be warranted. This was initially surprising because
we had always observed killing of CD41 T lymphocytes
with these isolates while using unfractionated PBLs. Our
data clearly showed that CD81 LAK cells were killing the
infected CD41 lymphocytes in the unfractionated PBL
cultures. It seems clear, now, that studies demonstrating
cytopathic effects in CD4 lymphocytes in unfractionated
PBL cultures following HIV infection need to consider the
role of CD81 LAK cells in this cytopathicity. Studying the
mechanisms of the two types of HIV-induced cytopathol-
ogy (i.e., direct virus killing and LAK cell-mediated killing)
using two well-documented methods (morphology and
agarose gel electrophoresis of DNA) demonstrated that
FIG. 6. LAK-mediated killing of K562, CEM, CEM.NKr, VB, ACH.2, and
35.8 cells. Target cells were labeled with 51Cr for 1 h at 37°C. Effector
cells were PHA-stimulated PBLs cultured in vitro in medium containing
IL-2 (20 units/ml) for 8 to 10 days. The targets were incubated with the
effectors (E:T ratio 5 20:1) for 4 h at 37°C. Normal PBLs were used as
negative control cells and were not killed by LAK cells. Data represent
means 6 SD of three independent experiments.
FIG. 7. LAK-mediated killing of HIVMCK-infected purified CD4
1 T lymphocytes. Target cells (infected and uninfected controls) were purified CD41
PBL PHA blasts 4 days postinfection (m.o.i ' 1), labeled with 51Cr for 12 h at 37°C, washed three times in medium, further incubated in medium for
1 h at 37°C, and washed two times in medium. Effector cells were PHA-stimulated uninfected or HIV-infected unfractionated PBLs (containing LAK
cells), cultured in vitro in medium containing IL-2 (20 units/ml) for 8 to 10 days. The effector and target cells were incubated together for 8 h at 37°C.
(A) PBL effectors incubated with autologous uninfected and HIVMCK-infected CD4 T lymphocyte targets. (B) Extent of lysis with either CD8
1 or CD41
effectors (after removal of CD41 or CD81 T lymphocytes from cultured unfractionated PBLs) incubated with autologous HIVMCK-infected CD4
1 T
lymphocyte target cells. (C) CD81 LAK effectors (after removal of CD41 T lymphocytes from unfractionated PBL PHA blasts) incubated with
MHC-mismatched HIVMCK-infected CD4 T lymphocyte target cells. E:T ratios are indicated in each panel. Data are representative of three independent
experiments; m and y are different PBL donors.
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cytopathic HIV-1 isolates (HIV213, IIIB, RF, and TP1) which
directly kill infected purified CD41 T lymphocyte blasts
kill predominantly via a necrotic mechanism. In contrast,
apoptosis is the major mechanism involved in CD81 LAK
cell-mediated killing of infected CD41 T lymphocytes.
Induction of apoptosis has been reported as a cytopathic
effect induced by HIV replication in vitro in several stud-
ies (Laurent-Crawford et al., 1991; Terai et al., 1991). Terai
et al. (1991) reported that HIV (LAV-1BRU) infection of a T
cell line, MT2, and PHA-stimulated unfractionated PBMC
induced DNA laddering pattern, indicating an apoptotic
process. Consistent with this, Martin et al., (1994) found
DNA ladder formation in HIV-1NY5-infected H9 cells and
purified CD41 T lymphocytes and HIV-1RF-infected CEM
and H9 cells. Those studies used only gel electrophore-
sis of DNA extracted from HIV-infected cells to evaluate
apoptosis, and the ladder pattern could barely be seen.
The apoptosis observed in HIV-infected whole PBLs was
probably due to CD81 LAK cell killing. Other studies
could not detect a DNA ladder after HIV infection of T cell
lines (Bergeron and Sodroski, 1992), and some studies
have shown that cytopathic HIV replication in T cell lines
caused increased cell membrane permeability and per-
turbed lipid synthesis proceeding death (Cloyd and Lynn,
1991). Subsequently, these cytopathic effects of HIV have
been mapped to a positively charged, 28-residue linear
sequence within the carboxyl terminus of HIV transmem-
brane (TM) protein (env 828-855)(Chernomordik et al.,
1994), and this observation was supported by findings
showing that HIV TM protein binds to calmodulin (Miller
et al., 1993b), which, in turn, perturbs membranes (Miller
et al., 1993a). Others have further documented host cell
membrane damage and increased permeability by both
ultrastructural studies (Fermin and Garry, 1992) and stud-
ies using voltage clamp and single-cell recording tech-
niques (Chernomordik et al., 1994). These changes are
characteristic of necrosis. Banda et al. reported that
cross-linking CD4 by gp120 could induce apoptosis in
normal CD41 T lymphocytes (Banda et al., 1992), but
other reports could not confirm that effect (Liegler and
FIG. 8. CD81 LAK-mediated killing of HIV-MCK-infected purified CD4
1 PBL PHA blasts is by induction of apoptosis. Purified CD4 T lymphocytes were
infected with HIVMCK at m.o.i ' 0.5–1 and cultured for 4 days. CD8
1 LAK prepared from similarly stimulated uninfected unfractionated PBL cultures
from the same donor were incubated with the infected CD41 T lymphocytes at a 1:1 ratio for 2 and 4 h (lanes 5 and 6, respectively) and harvested,
and DNA was extracted for agarose gel electrophoresis. (A) Lane 1 is a molecular marker for DNA. Lanes 2 and 3 are uninfected and HIVMCK-infected
purified CD41 T lymphocytes, respectively, without effectors added. Lane 4 is uninfected unfractionated PBLs without effectors added. (B) EM
photomicrographs of uninfected PBLs. (C) EM of HIVMCK-infected unfractionated PBLs showing characteristic changes of apoptosis.
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Stites, 1994; Martin et al., 1994; Oyaizu et al., 1993). Most
studies currently are focusing on induction of apoptosis
in HIV-infected or gp120-bound lymphocytes following
additional signals (TCR, etc.).
How HIV-1 infection causes depletion of CD41 T lym-
phocytes in vivo is not clear. In vivo studies have shown
that HIV infection is associated with apoptosis of T lym-
phocytes (both CD8 and CD4) directly or indirectly (Finkel
et al., 1995; Muro-Cacho et al., 1995), but some of the
induction of apoptosis of productivity infected cells may
be mediated by immune effectors (NK, CTL, LAK, ADCC).
Decreased LAK cell activity has been reported in some
HIV-infected subjects at early stages after infection
(Brenner, 1991) and its decline correlated with disease
progression (Brenner et al., 1994). This LAK cell activity
was largely in the CD81 subsets (Brenner et al., 1993).
Paradoxically, LAK cells derived from asymptomatic HIV-
1-infected individuals generally showed significantly el-
evated cytotoxic responses to HIV-1-infected targets rel-
ative to uninfected counterparts (Gryllis et al., 1992).
More recently, one study showed that CD81 T lympho-
cytes prevented HIV-1 infection in the SCID-hu-PBL ani-
mal model by a non-MHC-restricted mechanism (Kuyk et
al., 1994). These results suggest that CD81 LAK cells
may play an important role in HIV-1 immunosurveillance
and may contribute to the loss of productively infected
CD41 T lymphocytes in HIV-infected subjects. However,
it must be kept in mind that the frequency in vivo of
productively infected lymphocytes is very low (; 1 in
1023 to 1 in 1025 in blood; 1 in 1022 to 1 in 1024 in lymph
nodes)(Embretson et al., 1993; Nuoro et al., 1994), and
thus killing of these cells may be only a minor part of HIV
pathogenesis.
Our data do not address whether CD81 lymphocytes
also produce antiviral factors, in addition to possessing
LAK activity. Although recent reports showed that IL-16
(Baier et al., 1995) and/or the chemokines RANTES, MIP-
1a, and MIP-1b suppressed HIV-1 replication in CD4 T
lymphocytes (Cocchi et al., 1995), they appear not to be
cytolytic to the infected cells. Furthermore, there is no
evidence for the involvement of these factors in in vivo
depletion of infected CD4 T cells. It certainly is likely that
CD81 lymphocytes also produce such chemokines,
which have an inhibitory effect on HIV spread in vivo, but
the role of CD81 LAK cells in actual depletion of infected
FIG. 9. HIV213, HIVIIIB, and HIVTP-1, directly cytopathic for purified CD4
1 T lymphocytes, induced necrosis by 4 days postinfection. (A) Agarose gel
electrophoresis of DNA extracted from purified CD4 PBLs uninfected (lane 2) and infected with HIV213 (at 2 and 4 days postinfection; lanes 3 and 4,
respectively), HIVIIIB (lane 5), or HIVTP-1 (lane 6). Lane 1 contains 1-kb molecular markers. EM photomicrographs of HIV213-infected, purified CD4
1 T
lymphocytes harvested at 2 (B) and 4 (C) days postinfection showed characteristic changes of necrosis.
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CD41 T lymphocytes, and thus some degree of inhibition
of HIV replication, must be considered.
MATERIALS AND METHODS
Isolation of PBMC and panning for CD41 or CD81
T lymphocytes
Peripheral blood was obtained by venipuncture from
four healthy low-risk, HIV-negative donors (HIV antibody
negative). PBMC (peripheral blood mononuclear cells)
were isolated by centrifugation over Lymphocyte Sepa-
ration Medium (Organon Teknika Corp.) and washed
twice with Hanks’ balanced salt solution (HBSS). The cell
pellet was resuspended in RPMI 1640 (Gibco) supple-
mented with 15% fetal bovine serum (FBS), penicillin,
streptomycin, and L-glutamine (Sigma) at 1 3 106 cells/
ml, stimulated with phytohemagglutinin (PHA, 4 mg/ml,
Sigma), and seeded into 24-well tissue culture plates or
tissue culture flasks. After 2–3 days, interleukin-2 (IL-2,
20 units/ml) was added to the cultures. In some experi-
ments, after 3 to 5 days of culture, CD81 or CD41 T
lymphocytes were depleted to obtain purified CD41 or
CD81 T lymphocytes by panning as reported previously
(Williams and Cloyd, 1991). Briefly, petri dishes (100 mm
in diameter, 1 for 1.0–1.5 3 107 PBLs) were pretreated
with 10 ml of affinity-purified goat anti-mouse IgG (Sigma)
in HBSS (5 mg/ml) overnight at 4°C. The dishes were
washed with 10 ml of HBSS containing 2% FBS five times
and further incubated for 1 h at 4°C with 20 ml of the
same solution. PBLs were taken from the cultures (leav-
ing behind most of the adherent monocyte-derived mac-
rophages) and were incubated with OKT8 or OKT4 for 1 h
at 4°C with constant mixing. After incubation with OKT8
or OKT4 monoclonal antibodies, the PBLs were pelleted,
washed twice, resuspended in HBSS containing 2% FBS
(107 cells/10 ml), and placed onto the goat anti-mouse
IgG-coated plates for 3–4 h at 4°C with gentle tilting at
1.5–2 h. Nonadherent cells were then collected, washed
with HBSS containing 2% FBS, and cultured in medium
as mentioned above.
HIV stocks and infection of PBLs and purified CD41
T lymphocytes
Stocks of virus strains HIVMCK, MN, RF, IIIB, AC-1, and
TP-1 were made from 24-h harvests of acutely infected
H9 or CEM cells at their peaks of virus production (Cloyd
and Moore, 1990). All HIV-1 stocks were titrated on C8166
cells and TCID50 endpoints determined at 2 weeks post-
inoculation. Infection of PBLs was accomplished by in-
cubating cells with virus at m.o.is around 0.5 to 1.0 for
12 h at 37°C. Control cells were mock infected with cell
culture supernatants from uninfected CEM or H9 cul-
tures. The PBLs were centrifuged, washed, and resus-
pended in fresh medium. Half of the supernatant was
changed every 3 days. Cell viability was determined by
trypan blue exclusion.
Antibodies and flow cytometric analysis
For direct immunofluorescent staining, 5 3 105 PBLs
were incubated with 10 or 20 ml of either FITC- or PE-
conjugated monoclonal antibodies for 30 min at 4°C. The
amount of each antibody used was as recommended by
the suppliers and also titrated in our own experiments.
The cells were then washed twice with HBSS containing
2% FBS. After the second wash, the cell pellets were
resuspended in 2% paraformaldehyde and analyzed by
flow cytometry (Becton–Dickinson). For indirect staining,
after the second wash, the cell pellets were resus-
pended in the appropriate concentration of either FITC-
or PE-conjugated secondary antibody and incubated for
another 30 min at 4°C. After incubation, cells were fur-
ther prepared as above. In some experiments, dual stain-
ing with FITC- and PE-conjugated antibodies was em-
ployed and analyzed by flow cytometry. The antibodies
were obtained as follows: CD4-FITC, CD4-PE, CD8-PE,
and CD3-FITC were from Pharmingen (San Diego, CA);
OKT4, OKT8, and OKT3 were harvested from hybridomas
obtained form ATCC; goat anti-mouse IgG (GAM), GAM-
PE, GAM-FITC, goat anti-human IgG (GAH)-PE, GAH-
FITC were from Sigma (St. Louis, MO); and mouse anti-
CD16 was from AMAC, Inc (Westbrook, ME, a subsidiary
of Immunotech S. A. France). To determine cells produc-
ing HIV, we used appropriately diluted pooled sera de-
rived from AIDS patients as primary antibody followed by
staining with GAH-PE or -FITC. Normal human serum
(NHS) was used to monitor background staining.
Quantitation of virus released into cell culture
supernatants
Virus released into the culture supernatants was
quantitated using a commercial HIV-1 p24 antigen cap-
ture EIA kit (Coulter) at 3- to 4-day intervals. In each
experiment, a standard curve was constructed according
to the manufacturer’s instructions. The harvested super-
natants were appropriately diluted until the OD value fell
into the linear range of the standard curve. The amount
of p24 in each diluted sample was calculated according
to the OD value and the standard curve. The amount of
p24 in each sample was calculated by multiplying the
final value by the dilution factor.
Cell lines
The NK target cell line K562 was used as a positive
control in LAK cytotoxicity assays. The CD4-positive hu-
man cell lines CEM, CEM.NKr, and VB were used to
evaluate LAK cell activity. ACH.2 is an HIV-1 latently
infected T cell clone derived from HIVLAV-infected A3.01
CEM.NKr, and VB and ACH.2 cells were gifts from the
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NIH AIDS Repository. The 35.8 is a cell clone from HIV213-
infected CEM cells and constitutively produces infec-
tious virus (Li et al., 1996). All cells were cultured in RPMI
1640 medium supplemented with 10% FBS, penicillin,
streptomycin, and L-glutamine.
51Chromium-release assay
Cytotoxic activity against different targets (HIV-infected
or control targets) was assayed using a 51Cr-release
assay (Klimpel et al., 1989). One million target cells were
incubated in 0.2 ml of medium containing 100 mCi of 51Cr
overnight at 37°C. The cells were washed three times
with medium and further incubated in medium for 1 h.
After incubation, the cells were washed two times with
medium and then plated into 96-well plates at 5 3 104
cells per well. The remainder of the protocol followed
routine chromium-release assays except that the incu-
bation time was 8 h. Spontaneous release of 51Cr from
labeled targets was in the range of 10–30%.
Electron microscopic study of the morphology
of HIV-infected cells
At various times after infection, 2 3 106 cells (infected
and control) were centrifuged, washed with cold phos-
phate-buffered saline (PBS), and fixed in 2% glutaralde-
hyde–2% paraformaldehyde. The fixed cell pellet was
dehydrated and then embedded in Epon 812. Ultrathin
sections were processed and prepared for electron mi-
croscopic (EM) studies.
Evaluation of DNA fragmentation pattern
by gel electrophoresis
Total genomic DNA was isolated from cell pellets as
described (Terai et al., 1991). DNA samples (10 mg per
lane) were loaded into 0.8% agarose gels and electro-
phoresed. After staining the DNA with ethidium bromide,
the electrophoresed DNA was visualized in UV light and
photographed.
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